Capricor Therapeutics | CAPR - Assets


Capricor Therapeutics reported $326.28M in Assets for its fiscal quarter ending in March of 2026.





Assets Change Date
Alterity Therapeutics Limited AUD 37.98M 15.78M Dec/2025
Bioline Rx USD 39.8M 3.47M Sep/2025
Capricor Therapeutics USD 326.28M 29.66M Mar/2026
Cipla INR 424.96B 23.32B Mar/2026
Cytokinetics USD 1.27B 151.06M Mar/2026
Geron USD 534.12M 36.42M Mar/2026
Grifols EUR 23.15B 142.7M Dec/2025
Immunic USD 189.74M 165.69M Mar/2026
J&J USD 200.89B 1.68B Mar/2026
Plus Therapeutics USD 19.92M 3.59M Mar/2026
Prothena USD 349.89M 23.09M Mar/2026
PTC Therapeutics USD 2.87B 29.66M Mar/2026
Sarepta Therapeutics USD 3.18B 170.77M Mar/2026